Liver Metastases clinical trials

Explore recruiting liver metastases clinical trials.

Recruiting liver metastases studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Liver Metastases trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Focus Green: Fluorescence-guided resection Of Colorectal liver metastases Using SGM-101 and Indocyanine GREEN

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

COLLISION RELAPSE trial Recurrent colorectal liver metastases: repeat local treatment +/- neoadjuvant systemic therapy, a phase III prospective randomized controlled trial

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

Extended Criteria Treatment for Liver Metastases With Heavy Tumour Burden

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Dual-agent fluorescence-guided surgery for colorectal liver metastases

Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

PUMP-IT RCT: Hepatic arterial infusion PUMP chemotherapy combined with systemic therapy versus systemic therapy alone as Induction Therapy for initially unresectable colorectal liver metastases: a randomised controlled trial

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

INJECTABL-II trial: Dose finding, efficacy and immunological response of a novel immuno-adjuvant (IP-001) following microwave ablation or irreversible electroporation for colorectal liver metastases.

Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Liver Metastases trials by city

Liver Metastases in Toronto Liver Metastases in Vancouver Liver Metastases in Montreal Liver Metastases in Calgary Liver Metastases in Edmonton Liver Metastases in Ottawa Liver Metastases in Winnipeg Liver Metastases in Quebec City Liver Metastases in Hamilton Liver Metastases in Kitchener Liver Metastases in London Liver Metastases in Halifax Liver Metastases in New York Liver Metastases in Los Angeles Liver Metastases in Chicago Liver Metastases in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease